WASHINGTON, D.C. – The FDA’s latest guidance released over the weekend provided an accelerated path for high-complexity laboratories to support additional testing capacity in response to the COVID-19 outbreak. ... Read More
WASHINGTON, D.C. — Following the introduction of the Verifying Accurate Leading-edge IVCT Development Act of 2020, ACLA President Julie Khani issued the following statement: “ACLA and ... Read More
Following ongoing developments related to COVID-19 testing and response, included below is a statement from ACLA President Julie Khani following today’s meeting with the White ... Read More
WASHINGTON, D.C. — In light of recent concerns about the spread of COVID-19 in the United States, the American Clinical Laboratory Association (ACLA) is encouraging ... Read More
WASHINGTON, D.C. – ACLA is currently reviewing the FDA’s guidance for high complexity, CLIA-certified laboratories (which includes hospital, academic, and commercial laboratories) to provide coronavirus testing ... Read More
Commercial Labs Working Closely with Public Health Partners, Stand Ready To Support Increased Test Capacity If Needed WASHINGTON, D.C. — In response to the latest ... Read More
For seven years, Cid Lopez suffered from a painful mystery illness. Worst of all, after visiting a number of specialists and undergoing multiple surgeries – ... Read More
WASHINGTON, D.C.— In response to the Centers for Medicare and Medicaid Services’ (CMS) Final Decision Memo for Next Generation Sequencing (NGS) for Medicare Beneficiaries with ... Read More
WASHINGTON, D.C.—The American Clinical Laboratory Association (ACLA) today announced the promotions of Thomas Sparkman to Senior Vice President of Government Affairs and Policy, and Andrew ... Read More
As seniors brace for a new set of cuts to clinical lab services in January, Congress takes decisive action to halt faulty data collection process ... Read More
